SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 6.18 |
| Enterprise Value ($M) | 5.98 |
| Book Value ($M) | 2.58 |
| Book Value / Share | 0.30 |
| Price / Book | 2.40 |
| NCAV ($M) | 1.32 |
| NCAV / Share | 0.15 |
| Price / NCAV | 4.69 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.12 |
| Return on Assets (ROA) | -0.40 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.89 |
| Current Ratio | 1.56 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 5.85 |
| Assets | 7.11 |
| Liabilities | 4.53 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 7.76 |
| Operating Income | -3.92 |
| Net Income | -4.37 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -6.55 |
| Cash from Investing | 0.20 |
| Cash from Financing | 3.09 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Sternheim Eliezer | 6.30 | ||
| 13G/A | Armistice Capital, Llc | 4.99 | 4.84 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 58,269 | 199,404 | 29.22 | |
| 43,095 | 120,704 | 35.70 | |
| 21,992 | 130,849 | 16.81 | |
| 20,310 | 54,743 | 37.10 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| APRE – Aprea Therapeutics, Inc. | APVO – Aptevo Therapeutics Inc. |
| ARTL – Artelo Biosciences, Inc. | ASRT – Assertio Holdings, Inc. |
| ATHA – Athira Pharma, Inc. |
Financial data and stock pages provided by
Fintel.io